Missouri Trust & Investment Co raised its position in Bristol-Myers Squibb (NYSE:BMY – Free Report) by 20.8% in the 1st quarter, according to its most recent filing with the SEC. The firm owned 3,484 shares of the biopharmaceutical company's stock after acquiring an additional 600 shares during the period. Missouri Trust & Investment Co's holdings in Bristol-Myers Squibb were worth $241,000 at the end of the most recent reporting period. Other hedge funds also recently made changes to their positions in the company.

https://www.dailypolitical.com/2023/09/09/bristol-myers-squibb-nysebmy-shares-purchased-by-missouri-trust-investment-co.html

#dailypolitical